NCT03590366View on ClinicalTrials.gov

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

February 11, 2019

Study Completion Date

March 5, 2019

Conditions
Rosacea
Interventions
BIOLOGICAL

B244

B244 Suspension

BIOLOGICAL

Vehicle

Vehicle suspension

Trial Locations (9)

19103

Paddington Testing Co., Philadelphia

27612

Wake Research Associates, LLC, Raleigh

33027

FXM Research Miramar, Miramar

33126

Veritas Research Corp, Miami

33136

South Coast Research Center, Inc., Miami

33175

FXM Research Corp., Miami

33761

Tampa Bay Medical Research, Clearwater

77055

West Houston Clinical Research Service, Houston

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

AOBiome LLC
All Listed Sponsors
collaborator

bioRASI, LLC

INDUSTRY

lead

AOBiome LLC

INDUSTRY